ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training
- PMID: 30519292
- PMCID: PMC6269171
- DOI: 10.1183/20734735.026218
ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training
Abstract
ERS has developed a syllabus for postgraduate training in respiratory infections to guide programme designers http://ow.ly/xJ0R30m8CYB.
Conflict of interest statement
Conflict of interest: S. Aliberti has nothing to disclose. Conflict of interest: A. Farr is an employee of the European Respiratory Society. Conflict of interest: N. Tabin is an employee of the European Respiratory Society. Conflict of interest: F. Blasi has nothing to disclose. Conflict of interest: A. Torres has nothing to disclose. Conflict of interest: M. Woodhead reports an honorarium for a lecture at European Pneumoupdate in 2016, 2017 and 2018. Conflict of interest: G.B. Migliori has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose. Conflict of interest: G. Dimopoulos has nothing to disclose. Conflict of interest: J.D. Chalmers reports grants and personal fees from Glaxosmithkline, Grifols, Boehringer-Ingelheim and Insmed, grants from Astrazeneca and Bayer Healthcare, personal fees from Aradigm, Pfizer and Napp, all outside the submitted work. Conflict of interest: F.C. Ringshausen reports grants, personal fees and other from Bayer HealthCare (research support, consulting, lecture fees and support of patient educational events), grants and personal fees from Grifols Germany (research support and consulting), grants and personal fees from Insmed Germany (research support, consulting and reimbursement for study participation/patient recruitment), personal fees from Brahms/Thermo Fisher Scientific (consulting), personal fees from Astra Zeneca (lecture fees), personal fees and other from Forest (consulting and support of patient educational events), personal fees from Cellestis/Qiagen (lecture fees), personal fees and other from Chiesi (travel reimbursement and support of patient educational events), other from Abbott (support of patient educational events), personal fees and other from Gilead (travel reimbursement and support of patient educational events), other from Pfizer (support of patient educational events), other from Oxycare (support of patient educational events), other from Novartis (support of patient educational events), other from Heinen & Löwenstein (support of patient educational events), other from MSD (support of patient educational events), grants and other from InfectoPharm (research support and support of patient educational events), all outside the submitted work. Conflict of interest: M.R. Loebinger has nothing to disclose. Conflict of interest: R. Read has nothing to disclose. Conflict of interest: G. Rohde reports personal fees from Pfizer, Boehringer Ingelheim, Solvay, GSK, Essex Pharma, MSD, Roche and Novartis for lectures including service on speakers’ bureaus outside the submitted work and/or consultancy during advisory board meeting and personal fees from GSK for travel accommodations/meeting expenses, outside the submitted work.
References
-
- Global Health Estimates: Death by Cause, Age, by Country and by Region, 2000-2016. Geneva, World Health Organisation, 2018.
-
- World Health Organization World health statistics 2011. World Health Organization, 2011.
-
- Yousuf MI. Using experts’ opinions through Delphi technique. Pract Assess Res Eval 2007; 12: 1–8.
Publication types
LinkOut - more resources
Full Text Sources